OTC · CLCS
Cell Source, Inc.
$0.53+$0.06 (+13.97%)
Cell Source, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.45% below the high.
Loading market information…
OTC · UEEC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
United Health Products, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow United Health Products, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Henderson, Nevada, United Health Products, Inc., established in 1997, focuses on the creation, production, and distribution of hemostatic gauze solutions throughout the United States. This company primarily caters to the healthcare and wound management industries. Its prominent offering, HemoStyp hemostatic gauze, is engineered to manage bleeding and absorb fluids from superficial injuries. The firm serves a broad spectrum of clients, including hospitals, surgical facilities, medical clinics, military healthcare providers, hemodialysis centers, assisted living and nursing homes, and veterinary hospitals. Additionally, their products are utilized by emergency medical services (EMS), fire departments, various other first responders, and dental, oral, and maxillofacial surgery practices. The company adopted its current name in September 2010, having previously operated as United EcoEnergy Corp.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.53+$0.06 (+13.97%)
Cell Source, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.45% below the high.
$0.04+$0.01 (+33.33%)
CareView Communications, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.15-$0.00 (-1.36%)
Guided Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.15% below the high.
$0.03$0.00 (0.0%)
Quest PharmaTech Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.23% below the high.
$0.05$0.00 (0.0%)
Gemina Laboratories Ltd.’s quoted price sits in the lower half of its reported 52-week range, 85.46% below the high.
SEK 0.05+SEK 0.01 (+17.05%)
Immunovia AB’s quoted price sits in the lower half of its reported 52-week range, 85.51% below the high.
$0.01$0.00 (0.0%)
RYAH Group, Inc.: Healthcare · Medical - Healthcare Information Services.
$0.06+$0.00 (+5.45%)
Biotricity, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.17% below the high.
